Mankind Pharma Company Description
Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally.
The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases.
It also provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations.
The company offers its products primarily under the Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar brand names.
In addition, it engages in the trading and exporting of pharmaceutical and health care products; manufacturing of packing materials ayurvedic products, packing materials, bulk drugs, and consumer goods; real estate, leasing, and hospitality businesses; and provision of IT services.
Mankind Pharma Limited was founded in 1986 and is based in New Delhi, India.
Country | India |
Founded | 1986 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 19,540 |
CEO | Sheetal Arora |
Contact Details
Address: 262, Okhla Industrial Estate New Delhi, Delhi 110 020 India | |
Phone | 91 11 4654 1111 |
Website | mankindpharma.com |
Stock Details
Ticker Symbol | MANKIND |
Exchange | National Stock Exchange of India |
Fiscal Year | April - March |
Reporting Currency | INR |
ISIN Number | INE634S01028 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Sheetal Arora | Chief Executive Officer and Whole-Time Director |
Ramesh C. Juneja | Executive Chairman |
Rajeev Juneja | Vice Chairman and MD |
Satish Kumar Sharma | Whole-Time Director |
Ashutosh Dhawan MBA | Chief Financial Officer |
Chanakya Juneja | Director of Technology |
Pramod Gokhale | President - Group Chief Information Officer |
Dr. Anil Kumar | Chief Scientific Officer (Research Centre) |
Abhishek Agarwal | Head of Investor Relations |
Pradeep Chugh | Company Secretary and Compliance Officer |